Penelope A. Dandridge

Statistics

Publications

Citations

352

H-Index

Active since

1982

Affiliations

National Institute of Neurological Disorders and Stroke(Current)

Penelope A. Dandridge is an author at National Institute of Neurological Disorders and Stroke specializing in neuropharmacology, pharmacology, and drug discovery.

Top concepts

MedicineNeurosciencePharmacologyDrug DiscoveryNeuropharmacologyBiochemistryPharmacotherapyNatural SciencesMedicinal ChemistryOrganic Chemistry

Publications per year

1982–1986

Publications

Orally Active and Potent Inhibitors of γ-Aminobutyric Acid Uptake

Fadia E. Ali, William E. Bondinell, Penelope A. Dandridge et al. · Journal of Medicinal Chemistry · 1985 · 130 citations · Full text

Pharmacotherapy, Experimental Pharmacology, Molecular Pharmacology +16

Absolute stereochemistry and dopaminergic activity of enantiomers of 2,3,4,5-tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine

Carl Kaiser, Penelope A. Dandridge, Eleanor Garvey et al. · Journal of Medicinal Chemistry · 1982 · 82 citations · Full text

Organic Chemistry, Pharmacotherapy, R Isomer +16

[125I]SCH 23982: the ligand of choice for identifying the D-1 dopamine receptor

A Sidhu, Joop C. van Oene, Penelope A. Dandridge et al. · European Journal of Pharmacology · 1986 · 71 citations

Molecular Pharmacology, Medicine, D-1 Dopamine Receptor +8

Synthesis, resolution, absolute stereochemistry, and enantioselectivity of 3',4'-dihydroxynomifensine

Penelope A. Dandridge, Carl Kaiser, Martin Brenner et al. · Journal of Medicinal Chemistry · 1984 · 52 citations · Full text

Organic Chemistry, Dopamine Receptors, Pharmacotherapy +19

Dopamine receptor agonist activity of some 5-(2-aminoethyl)carbostyril derivatives

Carl Kaiser, Penelope A. Dandridge, Eleanor Garvey et al. · Journal of Medicinal Chemistry · 1985 · 17 citations · Full text

1–5 of 5